These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 20064928)

  • 1. Critical role of flanking residues in NGR-to-isoDGR transition and CD13/integrin receptor switching.
    Curnis F; Cattaneo A; Longhi R; Sacchi A; Gasparri AM; Pastorino F; Di Matteo P; Traversari C; Bachi A; Ponzoni M; Rizzardi GP; Corti A
    J Biol Chem; 2010 Mar; 285(12):9114-23. PubMed ID: 20064928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The neovasculature homing motif NGR: more than meets the eye.
    Corti A; Curnis F; Arap W; Pasqualini R
    Blood; 2008 Oct; 112(7):2628-35. PubMed ID: 18574027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic and tumor-targeted delivery of siRNA by cyclic NGR and isoDGR motif-containing peptides.
    Huang Y; Cheng Q; Jin X; Ji JL; Guo S; Zheng S; Wang X; Cao H; Gao S; Liang XJ; Du Q; Liang Z
    Biomater Sci; 2016 Mar; 4(3):494-510. PubMed ID: 26783563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NGR-TNF Engineering with an N-Terminal Serine Reduces Degradation and Post-Translational Modifications and Improves Its Tumor-Targeting Activity.
    Corti A; Gasparri AM; Sacchi A; Colombo B; Monieri M; Rrapaj E; Ferreri AJM; Curnis F
    Mol Pharm; 2020 Oct; 17(10):3813-3824. PubMed ID: 32805112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural basis for the interaction of isoDGR with the RGD-binding site of alphavbeta3 integrin.
    Spitaleri A; Mari S; Curnis F; Traversari C; Longhi R; Bordignon C; Corti A; Rizzardi GP; Musco G
    J Biol Chem; 2008 Jul; 283(28):19757-68. PubMed ID: 18480047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isoaspartate-dependent molecular switches for integrin-ligand recognition.
    Corti A; Curnis F
    J Cell Sci; 2011 Feb; 124(Pt 4):515-22. PubMed ID: 21282473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor activity of antimicrobial peptides containing CisoDGRC in CD13 negative breast cancer cells.
    Hou L; Zhao X; Wang P; Ning Q; Meng M; Liu C
    PLoS One; 2013; 8(1):e53491. PubMed ID: 23326440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isoaspartate-glycine-arginine: a new tumor vasculature-targeting motif.
    Curnis F; Sacchi A; Gasparri A; Longhi R; Bachi A; Doglioni C; Bordignon C; Traversari C; Rizzardi GP; Corti A
    Cancer Res; 2008 Sep; 68(17):7073-82. PubMed ID: 18757422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycine
    Corti A; Gasparri AM; Ghitti M; Sacchi A; Sudati F; Fiocchi M; Buttiglione V; Perani L; Gori A; Valtorta S; Moresco RM; Pastorino F; Ponzoni M; Musco G; Curnis F
    Adv Funct Mater; 2017 Sep; 27(36):. PubMed ID: 28979182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spontaneous formation of L-isoaspartate and gain of function in fibronectin.
    Curnis F; Longhi R; Crippa L; Cattaneo A; Dondossola E; Bachi A; Corti A
    J Biol Chem; 2006 Nov; 281(47):36466-76. PubMed ID: 17015452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biselectivity of isoDGR peptides for fibronectin binding integrin subtypes α5β1 and αvβ6: conformational control through flanking amino acids.
    Bochen A; Marelli UK; Otto E; Pallarola D; Mas-Moruno C; Di Leva FS; Boehm H; Spatz JP; Novellino E; Kessler H; Marinelli L
    J Med Chem; 2013 Feb; 56(4):1509-19. PubMed ID: 23362923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NGR-tagged nano-gold: A new CD13-selective carrier for cytokine delivery to tumors.
    Curnis F; Fiocchi M; Sacchi A; Gori A; Gasparri A; Corti A
    Nano Res; 2016 May; 9(5):1393-1408. PubMed ID: 27226823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NGR-peptide-drug conjugates with dual targeting properties.
    Enyedi KN; Tóth S; Szakács G; Mező G
    PLoS One; 2017; 12(6):e0178632. PubMed ID: 28575020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity relationships of linear and cyclic peptides containing the NGR tumor-homing motif.
    Colombo G; Curnis F; De Mori GM; Gasparri A; Longoni C; Sacchi A; Longhi R; Corti A
    J Biol Chem; 2002 Dec; 277(49):47891-7. PubMed ID: 12372830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and in vitro evaluation of cyclic NGR peptide targeted thermally sensitive liposome.
    Negussie AH; Miller JL; Reddy G; Drake SK; Wood BJ; Dreher MR
    J Control Release; 2010 Apr; 143(2):265-73. PubMed ID: 20067811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct structural requirements for binding of the integrins alphavbeta6, alphavbeta3, alphavbeta5, alpha5beta1 and alpha9beta1 to osteopontin.
    Yokosaki Y; Tanaka K; Higashikawa F; Yamashita K; Eboshida A
    Matrix Biol; 2005 Sep; 24(6):418-27. PubMed ID: 16005200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In Vivo Tumor Growth Inhibition and Antiangiogenic Effect of Cyclic NGR Peptide-Daunorubicin Conjugates Developed for Targeted Drug Delivery.
    Tripodi AAP; Ranđelović I; Biri-Kovács B; Szeder B; Mező G; Tóvári J
    Pathol Oncol Res; 2020 Jul; 26(3):1879-1892. PubMed ID: 31820302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrin αvβ3 and disulfide bonds play important roles in NGR-retargeted adenovirus transduction efficiency.
    Nestić D; Hozić A; Brkljača Z; Butorac A; Pažur K; Jullienne B; Cindrić M; Ambriović-Ristov A; Benihoud K; Majhen D
    Life Sci; 2022 Feb; 291():120116. PubMed ID: 34740576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NGR peptide ligands for targeting CD13/APN identified through peptide array screening resemble fibronectin sequences.
    Soudy R; Ahmed S; Kaur K
    ACS Comb Sci; 2012 Nov; 14(11):590-9. PubMed ID: 23030271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 68Ga-labeled cyclic NGR peptide for microPET imaging of CD13 receptor expression.
    Shao Y; Liang W; Kang F; Yang W; Ma X; Li G; Zong S; Chen K; Wang J
    Molecules; 2014 Aug; 19(8):11600-12. PubMed ID: 25100253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.